HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

More Supplements Making Anthrax Claims Targeted By FDA

This article was originally published in The Tan Sheet

Executive Summary

FDA recently sent five "cyber" letters to online marketers of non-colloidal silver supplements making fraudulent anthrax claims

You may also be interested in...



“Misbranded” Rosacea, Acne Treatments Targeted In FDA Warning Letters

Bass & Boney's Rosacea-Ltd III, which labeling claims is "designed specifically for skin that is sensitive or inflamed due to rosacea and seborrheic dermatitis," is one of several skin care products targeted in recent FDA warning letters

Colloidal Silver Antibiotic Superiority Claims Barred Under FTC Settlement

A Web site operator has been barred from representing colloidal silver as "superior to antibiotics in killing disease-causing organisms" or treating burns absent reliable scientific evidence, according to a Federal Trade Commission consent order

FDA, FTC, 30 State AGs Join Forces To Combat Fraudulent Anthrax Products

The Federal Trade Commission is renewing efforts to track down colloidal silver supplements sold online under a federal and state multi-agency campaign against fraudulent products indicated for anthrax

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS130519

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel